Exome Asset Management LLC: PRAXIS PRECISION MEDICINES I (PRAX): Quarterly 13F Position History
As of Q1 2026, Exome Asset Management LLC reported 45,469 shares of PRAXIS PRECISION MEDICINES I (PRAX), worth $14.6M and representing 8.6% of its 13F equity book. Quarter-over-quarter share count change: 12,653 (-21.8%) . The position first appeared in Q2 2025 and has been disclosed across 4 13F-HR filings in Pactolio's tracked window.
- 45,469Shares Held (Latest Filing)
- $14.6MReported Market Value (Latest Filing)
- 8.6%Portfolio Weight (% of 13F Equity Book)
- 12,653Quarter-over-Quarter Share Change
- -$2.5MQuarter-over-Quarter Value Change
- 101,996Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 4 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 45,469 | 12,653 | -21.8% | $14.6M | 8.6% | $322.2 |
| Q4 2025 | 58,122 | 43,874 | -43.0% | $17.1M | 8.5% | $294.7 |
| Q3 2025 | 101,996 | +42,994 | +72.9% | $5.4M | 3.6% | $53.0 |
| Q2 2025 | 59,002 | — | — | $2.5M | 2.0% | $42.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Exome Asset Management LLC first disclose a PRAX position in 13F-HR filings?
Exome Asset Management LLC first reported PRAXIS PRECISION MEDICINES I (PRAX) on its 13F-HR filing for the period ending 2025-06-30 (Q2 2025). The position has appeared on 4 reported quarters within Pactolio's tracked window.
What was Exome Asset Management LLC's most recent quarter-over-quarter share-count change in PRAX?
Between Q4 2025 and Q1 2026, Exome Asset Management LLC reduced its PRAX position by 12,653 shares (-21.8%), leaving 45,469 shares at a market value of $14.6M.
Does the implied price-per-share represent Exome Asset Management LLC's cost basis in PRAX?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.